{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:23:35Z","timestamp":1761906215029,"version":"build-2065373602"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Program of Guangzhou","award":["2023A03J0418"],"award-info":[{"award-number":["2023A03J0418"]}]},{"name":"Featured Clinical Technique of Guangzhou","award":["2023C-TS47"],"award-info":[{"award-number":["2023C-TS47"]}]},{"name":"Fund for Clinical Research of the Second Affiliated Hospital of Guangzhou Medical University"},{"name":"Plan on Enhancing Scientific Research in GMU","award":["GMUCR2025-02002"],"award-info":[{"award-number":["GMUCR2025-02002"]}]},{"name":"Guangzhou Medical University Student Innovation Ability Promoting Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04071-y","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:20:05Z","timestamp":1761906005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic hyperthermic intraperitoneal chemotherapy is associated with improved disease-free survival in pathologic T4 colorectal cancer: a propensity score\u2013matched cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Rongpeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhicheng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"4071_CR1","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"key":"4071_CR2","doi-asserted-by":"publisher","unstructured":"Klaver CEL, van Huijgevoort NCM, de Buck van Overstraeten A, Wolthuis AM, Tanis PJ, van der Bilt JDW, et al. Locally advanced colorectal cancer: true peritoneal tumor penetration is associated with peritoneal metastases. Ann Surg Oncol. 2018;25(1):212\u201320. https:\/\/doi.org\/10.1245\/s10434-017-6037-6.","DOI":"10.1245\/s10434-017-6037-6"},{"key":"4071_CR3","doi-asserted-by":"publisher","unstructured":"Hossain MS, Karuniawati H, Jairoun A, Urbi Z, Ooi D, John A, et al. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers. 2022;14(7):1732. https:\/\/doi.org\/10.3390\/cancers14071732","DOI":"10.3390\/cancers14071732"},{"key":"4071_CR4","doi-asserted-by":"publisher","unstructured":"Schellenberg AE, Moravan V, Christian F. A competing risk analysis of colorectal cancer recurrence after curative surgery. BMC Gastroenterol. 2022;22:95. https:\/\/doi.org\/10.1186\/s12876-022-02161-9.","DOI":"10.1186\/s12876-022-02161-9"},{"key":"4071_CR5","doi-asserted-by":"publisher","unstructured":"Uppal A. ASO author reflections: peritoneal metastases after curative-intent radical resection of T4 colon cancers. Ann Surg Oncol. 2022;29:4234. https:\/\/doi.org\/10.1245\/s10434-022-11558-5.","DOI":"10.1245\/s10434-022-11558-5"},{"key":"4071_CR6","doi-asserted-by":"publisher","unstructured":"Xia W, Geng Y, Hu W. Peritoneal metastasis: a dilemma and challenge in the treatment of metastatic colorectal cancer. Cancers. 2023;15(23):5641. https:\/\/doi.org\/10.3390\/cancers15235641.","DOI":"10.3390\/cancers15235641"},{"key":"4071_CR7","doi-asserted-by":"publisher","unstructured":"Hamm JJM, Berg R van den, Andrinopoulou E, Zwanenburg ES, Musters G, Tanis P, et al. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases: individual patient data meta-analysis. Br J Surg. 2025;112(4):znaf076. https:\/\/doi.org\/10.1093\/bjs\/znaf076.","DOI":"10.1093\/bjs\/znaf076"},{"key":"4071_CR8","doi-asserted-by":"publisher","unstructured":"Klaver C, Musters G, Bemelman W, Punt C, Verwaal V, Dijkgraaf M, et al. Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial. BMC Cancer. 2015;15:428. https:\/\/doi.org\/10.1186\/s12885-015-1430-7.","DOI":"10.1186\/s12885-015-1430-7"},{"key":"4071_CR9","doi-asserted-by":"publisher","unstructured":"Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17(12):1709\u201319. https:\/\/doi.org\/10.1016\/S1470-2045(16)30500-9.","DOI":"10.1016\/S1470-2045(16)30500-9"},{"key":"4071_CR10","doi-asserted-by":"publisher","unstructured":"Sun BJ, Daniel SK, Lee B. The role of prophylactic and adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in prevention of peritoneal metastases in advanced colorectal cancer. J Clin Med. 2023;12(20):6443. https:\/\/doi.org\/10.3390\/jcm12206443.","DOI":"10.3390\/jcm12206443"},{"issue":"2","key":"4071_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, Go\u00e9r\u00e9 D, Ghouti L, Pocard M, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366. https:\/\/doi.org\/10.1016\/S1470-2045(20)30599-4.","journal-title":"Lancet Oncol."},{"issue":"7","key":"4071_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamasurg.2023.0662","volume":"158","author":"A Arjona-S\u00e1nchez","year":"2023","unstructured":"Arjona-S\u00e1nchez A, Espinosa-Redondo E, Guti\u00e9rrez-Calvo A, Segura-Sampedro JJ, P\u00e9rez-Viejo E, Concepci\u00f3n-Mart\u00edn V, et al. Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced colon cancer: a phase 3 randomized clinical trial. JAMA Surg. 2023;158(7):683\u201391. https:\/\/doi.org\/10.1001\/jamasurg.2023.0662.","journal-title":"JAMA Surg."},{"key":"4071_CR13","doi-asserted-by":"publisher","unstructured":"Sommariva A, Tonello M, Coccolini F, De Manzoni G, Delrio P, Pizzolato E, et al. Colorectal cancer with peritoneal metastases: the impact of the results of PROPHYLOCHIP, COLOPEC, and PRODIGE 7 trials on peritoneal disease management. Cancers. 2023;15(1):165. https:\/\/doi.org\/10.3390\/cancers15010165.","DOI":"10.3390\/cancers15010165"},{"key":"4071_CR14","doi-asserted-by":"publisher","unstructured":"Nagata H, Kawai K, Hata K, Tanaka T, Nozawa H, Ishihara S. Laparoscopic surgery for T4 colon cancer: a risk factor for peritoneal recurrences? Surgery. 2020;168(1):119\u201324. https:\/\/doi.org\/10.1016\/j.surg.2020.02.026.","DOI":"10.1016\/j.surg.2020.02.026"},{"key":"4071_CR15","doi-asserted-by":"publisher","unstructured":"Rietveld PCS, Guchelaar NAD, Sassen SDT, Koch BCP, Mathijssen RHJ, Koolen SLW. A clinical pharmacological perspective on intraperitoneal chemotherapy. Drugs. 2025;85:931\u201343. https:\/\/doi.org\/10.1007\/s40265-025-02195-9.","DOI":"10.1007\/s40265-025-02195-9"},{"key":"4071_CR16","doi-asserted-by":"publisher","first-page":"116820","DOI":"10.1016\/j.biopha.2024.116820","volume":"176","author":"PCS Rietveld","year":"2024","unstructured":"Rietveld PCS, Guchelaar NAD, van Eerden RAG, de Boer NL, de Bruijn P, Sassen SDT, et al. Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastases. Biomed Pharmacother. 2024;176:116820. https:\/\/doi.org\/10.1016\/j.biopha.2024.116820","journal-title":"Biomed Pharmacother"},{"key":"4071_CR17","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00228-008-0511-9","volume":"64","author":"H Mahteme","year":"2008","unstructured":"Mahteme H, Wallin I, Glimelius B, P\u00e5hlman L, Ehrsson H. Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion. Eur J Clin Pharmacol. 2008;64:907\u201311. https:\/\/doi.org\/10.1007\/s00228-008-0511-9.","journal-title":"Eur J Clin Pharmacol"},{"key":"4071_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/bcp.13773","volume":"85","author":"LAW de Jong","year":"2019","unstructured":"de Jong LAW, Elekonawo FMK, de Reuver PR, Bremers AJA, de Wilt JHW, Jansman FGA, et al. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure. Br J Clin Pharmacol. 2019;85(1):47\u201358. https:\/\/doi.org\/10.1111\/bcp.13773","journal-title":"Br J Clin Pharmacol"},{"key":"4071_CR19","doi-asserted-by":"publisher","unstructured":"Klaver CEL, Wisselink DD, Punt CJA, Snaebjornsson P, Crezee J, Aalbers AGJ, et al. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol. 2019;4(10):761\u201370. https:\/\/doi.org\/10.1016\/S2468-1253(19)30239-0.","DOI":"10.1016\/S2468-1253(19)30239-0"},{"key":"4071_CR20","doi-asserted-by":"publisher","unstructured":"Zhang R, Wu X, Wan D, Lin J, Ding P, Liao L, et al. Long-term outcomes of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection (IOCCRC): a randomized, multicenter, prospective, phase III trial. Int J Surg. 2024;110(10):6622\u201331. https:\/\/doi.org\/10.1097\/JS9.0000000000001301.","DOI":"10.1097\/JS9.0000000000001301"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04071-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04071-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04071-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:20:06Z","timestamp":1761906006000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04071-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4071"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04071-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Second Affiliated Hospital of Guangzhou Medical University (approval no. LYZX-2025-147-01). Given the retrospective design and use of de-identified data, the requirement for additional informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"414"}}